XML 38 R22.htm IDEA: XBRL DOCUMENT
v3.24.3

Net Loss per Share | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2024 | Dec. 31, 2023
Earnings Per Share [Abstract] |  |
Net Loss per Share |
13. | Net Loss per Share
Basic and diluted net loss per share was calculated as follows:
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  | $ | (9,004 | ) |  | $ | (21,630 | ) |  | $ | (5,580 | ) |  | $ | (61,427 | )
Cumulative undeclared preferred dividends to participating securities (Legacy Series D convertible preferred stock) |  |  | — |  |  |  | (255 | ) |  |  | — |  |  |  | (1,697 | )
Net loss attributable to common shareholders |  | $ | (9,004 | ) |  | $ | (21,885 | ) |  | $ | (5,580 | ) |  | $ | (63,124 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic and diluted weighted-average common stock outstanding |  |  | 64,086,265 |  |  |  | 40,335,457 |  |  |  | 53,310,214 |  |  |  | 31,558,538 |
Net loss per share, basic and diluted |  |  | (0.14 | ) |  |  | (0.54 | ) |  |  | (0.10 | ) |  |  | (2.00 | )
The Company’s potentially dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of shares of Common Stock outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential shares of Common Stock, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:
|  | As of September 30, |
|  | 2024 |  |  | 2023 |
Outstanding options to purchase Common Stock |  |  | 7,108,316 |  |  |  | 4,270,229 |
Restricted Stock Units |  |  | 530,778 |  |  |  | 429,321 |
Series A Preferred Stock |  |  | 2,260,159 |  |  |  | — |
Warrants to purchase Common Stock |  |  | 19,231,301 |  |  |  | 404,988 |
Shares of Common Stock issued upon the exercise of Public Warrants |  |  | 18,759,554 |  |  |  | 18,759,838 |
Earn-Out Shares |  |  | 9,000,000 |  |  |  | 9,000,000 |
Convertible Notes |  |  | 479,196 |  |  |  | — |
Total |  |  | 57,369,304 |  |  |  | 32,864,376 |
13. | Net Loss per Share
Basic and diluted net loss per share was calculated as follows:
|  | Year Ended December 31, |
|  | 2023 |  |  | 2022 |
Numerator: |  |  |  |  |  |  |  |
Net loss |  | $ | (80,607 | ) |  | $ | (37,744 | )
Cumulative undeclared dividends to participating securities (Legacy Series D convertible preferred stock) |  |  | (1,697 | ) |  |  | (2,907 | )
Net loss attributable to common stockholders |  | $ | (82,304 | ) |  | $ | (40,651 | )
Denominator: |  |  |  |  |  |  |  |
Basic and diluted weighted-average common stock outstanding |  |  | 35,581,656 |  |  |  | 26,918,484 |
Net loss per share attributable to common stockholders, basic and diluted (1) |  | $ | (2.31 | ) |  | $ | (1.51 | )
(1) | The weighted-average common shares and thus net loss per share calculations and potentially dilutive security amounts for all periods prior to the Business Combination have been retrospectively adjusted to the equivalent number of shares outstanding immediately after the Business Combination to effect the reverse capitalization. See Note 3 for further information.
The Company’s potentially dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:
|  | Year Ended December 31, |
|  | 2023 |  |  | 2022 |
Outstanding options to purchase common stock |  |  | 3,886,038 |  |  |  | 4,301,960 |
Restricted Stock Units |  |  | 643,635 |  |  |  | 1,415,104 |
Warrants to purchase preferred stock (as converted to warrants to purchase common stock) |  |  | 138,857 |  |  |  | 297,854 |
Warrants to purchase common stock |  |  | 264,801 |  |  |  | 138,857 |
Shares of Common Stock issued upon the exercise of Public Warrants |  |  | 18,759,838 |  |  |  | — |
Earn-Out Shares |  |  | 9,000,000 |  |  |  | — |
Convertible notes (as converted to common stock) |  |  | — |  |  |  | 171,256 |
Total |  |  | 32,693,169 |  |  |  | 6,325,031 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration